# FDA Inspection 1062705 - SGS France - June 22, 2018

Source: https://www.keypedia.com/records/fda_inspections/sgs-france/64159143-f6f1-46a1-a8a3-1e8cf51def28
Source feed: FDA_Inspections

> FDA Inspection 1062705 for SGS France on June 22, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1062705
- Company Name: SGS France
- Inspection Date: 2018-06-22
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1275370 - 2024-01-19](https://www.keypedia.com/records/fda_inspections/sgs-france/2068e554-0de4-4dd8-b6b9-500110785aee)
- [FDA Inspection 945927 - 2015-09-17](https://www.keypedia.com/records/fda_inspections/sgs-france/62d23bbc-cc48-440c-9da7-47588e2f6a37)
- [FDA Inspection 841077 - 2013-06-20](https://www.keypedia.com/records/fda_inspections/sgs-france/543f08e2-f1d0-4963-a862-4b7a38e459a7)
- [FDA Inspection 631854 - 2009-10-29](https://www.keypedia.com/records/fda_inspections/sgs-france/4801a32c-9386-412e-8cd4-91c688688f14)

Company: https://www.keypedia.com/companies/sgs-france/e79e59a7-31e7-4536-94ef-f3cdc0fa4c12

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c